K2 Principal Fund’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-722,804
Closed -$94.3K 330
2022
Q4
$94.3K Sell
722,804
-501,147
-41% -$62.7K 0.01% 168
2022
Q3
$147K Sell
1,223,951
-25,784
-2% -$2.94K 0.02% 183
2022
Q2
$100K Hold
1,249,735
0.01% 246
2022
Q1
$150K Sell
1,249,735
-113,921
-8% -$18.2K 0.01% 214
2021
Q4
$251K Hold
1,363,656
0.02% 267
2021
Q3
$273K Buy
+1,363,656
New +$301K 0.02% 237
2021
Q2
Sell
-983,100
Closed -$203K 443
2021
Q1
$177K Buy
+983,100
New +$229K 0.01% 281

Other funds holding VHAQ.RT

K2 Principal Fund's VHAQ.RT Position: Q1 2023 in Review

K2 Principal Fund sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2023, closing a stake of 722,804 shares — an estimated $94.3K sold.

K2 Principal Fund first reported a position in VHAQ.RT in Q1 2021 and held it in 7 quarters. The position peaked at $273K in Q3 2021. 25 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2023.

  • K2 Principal Fund reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2023 after selling out during the quarter.
  • K2 Principal Fund sold 722,804 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2023, an estimated $94.3K.
  • K2 Principal Fund first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q1 2021 and held it in 7 quarters.
  • K2 Principal Fund's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $273K in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2023.

Based on K2 Principal Fund's 13F filing for Q1 2023, filed 11 May 2023.